MedPath

Manipulating Tobacco Constituents in Female Menthol Smokers

Not Applicable
Completed
Conditions
Nicotine Dependence
Registration Number
NCT02048852
Lead Sponsor
UConn Health
Brief Summary

This study examines the potential effect of reducing nicotine content or menthol or both in women of reproductive age, a vulnerable population identified by the FDA in need of further research.

Detailed Description

Study is designed to address the following questions that have been outlined by the FDA as particular areas of interest:

1. What are the factors, including menthol and other flavorings that influence the appeal of tobacco products to vulnerable populations: What is the impact of these factors on cessation, switching tobacco products and multiple use?

2. What is the potential impact of modifying nicotine levels on dependence, and smoking rate and cessation, as well as patterns of switching products and use of multiple tobacco products?

3. Beyond nicotine, what other constituents enhance addictive properties?

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
381
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
The goal of the cigarette conditions is to find the impact of varying nicotine and menthol concentrations on smoking rate and abstinence.12 weeks

Alter the nicotine and menthol concentrations of cigarettes administered to subjects as randomized.

Secondary Outcome Measures
NameTimeMethod
Toxicant Exposure12 weeks

Examine the effects of reduced nicotine and menthol removal on toxicant exposure for the outcomes-- cotinine, exhaled carbon monoxide, and urine carcinogens and other tobacco specific nitrosamines.

Trial Locations

Locations (2)

UCONN Health Center

🇺🇸

Farmington, Connecticut, United States

Hartford Hospital

🇺🇸

Hartford, Connecticut, United States

UCONN Health Center
🇺🇸Farmington, Connecticut, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.